Prot# M03-607: A Phase 3 Multicenter Study of the Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects with Active Ankylosing Spondylitis

Project: Research project

Project Details

StatusFinished
Effective start/end date3/24/04 → 3/24/06

Funding

  • Abbott Laboratories (M03-607)